KCNMA1 and breast carcinoma: Further studies are required in order to identify the miRNAs, including miR-9, miR-17-5p, miR-135a, and miR-449a, that contribute to KCa1.1 translational repression via mRNA degradation in AR-overexpressing breast cancer tissues.